Seeking Alpha

Questcor (QCOR +2.3%) rallies after SunTrust and Lazard respond positively to a...

Questcor (QCOR +2.3%) rallies after SunTrust and Lazard respond positively to a UnitedHealth/Oxford policy update letter (.pdf) regarding Acthar gel coverage, which produced a selloff on Friday. SunTrust argues the update should reassure investors Acthar has value in treating nephrology and MS, while Lazard claims it's a positive given investor fears following Aetna's move to limit coverage. 40.3% of Questcor's float was shorted as of Sep. 14.
Comments (1)
  • Analysts botched this one on Friday.

     

    UHS bulletin was very positive news for QCOR--basically solidified their revenue base and set the stage for the company to grow scrips into the foreseeable future.
    8 Oct 2012, 02:23 PM Reply Like
DJIA (DIA) S&P 500 (SPY)